semaglutide for eating disorder Concerns over Ozempic misuse and risks prompt calls increased screening From a new Perspective by

Many healthcare professionals are concerned that those with restrictive eating disorders should not be on appetite-suppressant drugs, says Pamela Keel, a psychologist and eating disorder expert at Florida State University

In a retrospective study completed by Nadeem et al., it was shown that GLP-1 RAs are associated with an overall fourfold increase in the retention of gastric contents in both diabetic and non-diabetic patients ( p -value 0.8 mL/kg of gastric fluid content (measured from the aspiration/suction canister)

Administration Protocol: Wash your hands thoroughly and clean the skin site with an alcohol wipe

Ozempic (semaglutide) administration (semaglutide) administration Thinnest needle (32G, 4 mm) on a once-weekly GLP-1 RA included with each pen 1 1 Red Label Pen that delivers doses of 0.25 mg and 0.5 mg Contains 2 mg of Ozempic Delivers only the starting dose of 0.25 mg and a maintenance dose of 0.5 mg Blue Label Pen that delivers doses of 1 mg Contains 4 mg of Ozempic Delivers only the maintenance dose of 1 mg Yellow Label Pen that delivers doses of 2 mg Contains 8 mg of Ozempic Delivers only the maximum maintenance dose of 2 mg Steps to deliver your dose 1 1 No matter if a patient is initiating, maintaining, or escalating their Ozempic pen dose, inform them to follow these steps for proper administration

who described it to be upregulated in colorectal adenomas and CRC (118)

GLP-1 is a synthetic version of a naturally occurring hormone in your body called an incretin